title: How can we explain the gap between randomised studies and 'real life' practice in postoperative transfusion triggers? Do we need to change recommended thresholds for transfusion?
authors.forename: Nadia
authors.initials: N
authors.lastname: Rosencher
authors.forename: Yves
authors.initials: Y
authors.lastname: Ozier
authors.forename: François
authors.initials: F
authors.lastname: Souied
authors.forename: André
authors.initials: A
authors.lastname: Lienhart
authors.forename: Charles-Marc
authors.initials: CM
authors.lastname: Samama
mesh_terms: D000758:Anesthesia / Q000009:adverse effects; D001803:Blood Transfusion / Q000592:standards*; D003422:Critical Care; D004912:Erythrocytes / Q000166:cytology; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D007700:Kinetics; D011184:Postoperative Period; D016032:Randomized Controlled Trials as Topic / Q000592:standards* / Q000639:trends; D012306:Risk; D014777:Virus Diseases / Q000517:prevention & control